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Purpose: To investigate whether cellular imaging by using ultra-
small superparamagnetic iron oxide (USPIO)–enhanced 
magnetic resonance (MR) imaging can allow detection 
and quantification of adipose tissue macrophage–related 
inflammation within adipose tissue in a mouse model.
Materials and 
Methods:
Experimental protocols were conducted in accordance 
with French government policies. Adipose tissue macro-
phages were detected and quantified with a 4.7-T MR 
imager in ob/ob obese mice on the basis of the signal 
variance of adipose tissue triggered by injection of P904 
iron oxide nanoparticles (USPIO). Mice were either intra-
venously injected with 1000 µmol of iron per kilogram of 
body weight of P904 (10 ob/ob and 11 ob/+) or used as 
noninjected control animals (seven ob/ob and six ob/+). 
Three-dimensional T2*-weighted gradient-echo MR im-
ages were acquired 10 days after intravenous injection. 
MR imaging signal variance in mice was correlated to ad-
ipose tissue macrophage quantification by using monoclo-
nal antibody to F4/80 immunostaining, to proinflamma-
tory marker quantification by using reverse transcription 
polymerase chain reaction (CCl2, Tnfa, Emr1), and to 
P904 quantification by using electron paramagnetic res-
onance imaging. Quantitative data were compared by us-
ing the Mann-Whitney or Student t test, and correlations 
were performed by using the Pearson correlation test.
Results: MR imaging measurements showed a significant increase in 
adipose tissue signal variance in ob/ob mice compared with 
ob/+ controls or noninjected animals (P , .0001), which 
was consistent with increased P904 uptake by adipose tis-
sue in ob/ob mice. There was a significant and positive cor-
relation between adipose tissue macrophage quantification 
at MR imaging and P904 iron oxide content (r = 0.87, P 
, .0001), adipose tissue macrophage–related inflammation 
at immunohistochemistry (r = 0.60, P , .01), and adipose 
tissue proinflammatory marker expression (r = 0.55, 0.56, 
and 0.58 for CCl2, Tnfa, and Emr1, respectively; P , .01). 
Conclusion: P904 USPIO–enhanced MR imaging is potentially a tool 
for noninvasive assessment of adipose tissue inflammation 
during experimental obesity. These results provide the ba-
sis for translation of MR imaging into clinical practice as a 
marker of patients at risk for metabolic syndrome.
q RSNA, 2012
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at 7, 10, and 14 weeks old were used 
for animal experiments. Twenty-one 
mice were injected with P904 (10 ob/ob 
and 11 ob/+), and 13 mice were used as 
noninjected controls (seven ob/ob and 
six ob/+). Seven- (n = 4), 10- (n = 2), 
and 14-week-old (n = 4) ob/ob mice un-
derwent P904 injection, while 7- (n = 
4) and 10-week-old ob/ob mice (n = 3)
served as noninjected controls. Seven-
(n = 4), 10- (n = 3), and 14-week-old (n
= 4) ob/+ mice underwent P904 injec-
tion, while 7- (n = 4) and 10-week-old
(n = 2) ob/+ mice served as noninjected
controls. MR imaging was performed
10 days after P904 injection (Fig 1).
Imaging Agent
USPIO P904 was obtained from Guer-
bet. USPIO P904 is made of a ma-
ghemite core coated with a low-molec-
ular-weight amino-alcohol derivative of 
glucose (P904) with a hydrated particle 
diameter of 21 nm. After intravenous 
injection of 200 mmol of iron per kilo-
gram of body weight of P904 in healthy 
mice, the known half-life a is 15.7 mi-
nutes and half-life b is 942.8 minutes, 
accounting for a clearance of 0.73 mL/
min · kg. A dose of 1000 mmol of iron 
per kilogram of P904 was used in this 
experimental setup. The P904 was in-
jected intravenously through the retro-
orbital sinus vein.
studies have suggested that ultrasmall 
superparamagnetic iron oxide (USPIO) 
can enable macrophage-specific im-
aging at a cellular level (11). Used as 
contrast agents, USPIOs are taken up 
by macrophages, which can be detected 
at magnetic resonance (MR) imaging. 
Hence, macrophage infiltration within 
atherosclerotic vascular walls can be 
detected, localized, and quantified at 
USPIO-enhanced MR imaging (12). The 
use of a USPIO contrast agent made of 
a maghemite core coated with a low-
molecular-weight amino-alcohol deriv-
ative of glucose (P904) has recently 
been reported. Because of its high re-
laxivity and rapid blood-pool clearance, 
this contrast agent has been used for 
MR imaging detection of macrophages 
within atherosclerotic aortic walls of 
hyperlipidemic rabbits (13) or in apoli-
poprotein E mice models (14). We hy-
pothesized that intravenously injected 
P904 particles could be taken up by 
adipose tissue macrophages and could 
hence influence the signal intensity of 
adipose tissue in obese mice.
Our purpose was to investigate 
whether cellular imaging by using US-
PIO-enhanced MR imaging can allow de-
tection and quantification of adipose tis-
sue macrophage–related inflammation 
within adipose tissue in a mouse model.
Materials and Methods
One author (S.B.), an employee of 
Guerbet (Aulnay-sous-Bois, France), 
provided P904 contrast agent for the 
experiments. The other authors, who 
are not employees of or consultants 
for Guerbet, retained full control of 
the data and information submitted for 
publication.
Animals
Experimental protocols were conducted 
in accordance with French government 
policies (Veterinary Services of Health 
and Animal Production, French Min-
istry of Agriculture). We selected a 
leptin-deficient obese mouse (ob/ob) 
model that shows progressive obesity, 
insulin resistance, and dyslipidemia as a 
function of age (15). A total of 34 mice 
(Janvier, Le Genest-Saint-Isle, France) 
Obesity-related disorders—includ-ing type 2 diabetes, cardiovas-cular disease, hypertension, and 
nonalcoholic fatty liver disease (1)—are 
reaching epidemic proportions world-
wide (2). Obesity is associated with 
chronic low-grade inflammation of the 
adipose tissue mediated by adipose tis-
sue macrophage infiltration (3). The 
adipose tissue produces proinflammato-
ry cytokines and chemoattractant cyto-
kines that accompany the development 
of insulin resistance (4,5). Accumulat-
ing evidence suggests that macrophage 
infiltration within expanding adipose 
tissue directly contributes to the in-
creased levels of inflammatory markers 
observed in obese patients (6,7). In ad-
ipose tissue, fat-laden adipocytes pro-
mote the recruitment of adipose tissue 
macrophage and further amplification 
of local inflammation (8). Hence, ad-
ipose tissue macrophages play a key 
role in the inflammatory response to 
obesity and in the development of obe-
sity-related comorbidities (9). To date, 
however, noninvasive detection of mac-
rophage-related inflammation accom-
panying obesity remains indirect and 
fails to quantify macrophage burden 
within adipose tissue (10). Because ad-
ipose tissue macrophages play a pivotal 
role in the initiation of obesity-related 
disorders, their early detection could 
be useful in preclinical diagnosis of 
this syndrome. Preclinical and clinical 
Advances in Knowledge
 n Ultrasmall superparamagnetic 
iron oxide–enhanced MR imaging 
after P904 intravenous injection 
enables imaging and quantitation 
of adipose tissue macrophages in 
a rodent model of obesity.
 n MR imaging signal variance in 
adipose tissue is correlated to 
P904 uptake (r = 0.87) and to 
macrophage-related adipose 
tissue inflammation characterized 
by immunohistochemical F4/80 
staining (r = 0.60) and expres-
sion of CCl2, Tnfa, and Emr1 
messenger RNA proinflammatory 
markers (r = 0.55, 0.56, and 
0.58, respectively).
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Immunohistochemistry
F4/80 was used as a marker of mature 
macrophages. Immunohistochemical 
detection of F4/80 was performed in 
epididymal adipose, formalin-fixed, par-
affin-embedded tissue sections (8 µm) 
by using a nondiluted antibody to F4/80 
(Serotec MCA 497; AbD Serotec, Col-
mar, France) and a biotinylated second-
ary antibody (1/50, Serotec AAR10B; 
AbD Seortec), as previously described 
(3). The signal was amplified with 
phosphatase alkaline-conjugated strep-
tavidin (1/20, Serotec; AbD Serotec), 
and alkaline phosphatase activity was 
revealed by using a fast red substrate-
chromogen system (DakoCytomation, 
Trappes, France). The percentage of 
F4/80 positive cells within epididymal 
adipose tissue was determined by an 
author (V.D., a liver biology specialist 
with 8 years of expertise) by visually 
counting the positive F4/80 cells.
RNA Extraction
The induction of the messenger RNA 
expression of proinflammatory markers 
(CCl2, Tnfa, and Emr1) in ob/ob mice 
was quantified as previously described 
different sections in each animal. Sec-
tions were selected in the center of the 
subcutaneous adipose tissue volume. 
Regions of interest were manually po-
sitioned within the epididymal adipose 
tissue, avoiding vessels, subcutaneous 
adipose tissue, and skin, allowing com-
putation of mean signal intensity within 
the epididymal adipose tissue and cor-
responding standard deviation. The 
mean sizes of epididymal adipose tissue 
regions of interest were 209 pixels 6 
40 (standard deviation) (range, 36–260 
pixels) for ob/+ mice and 1406 pixels 6 
475 (standard deviation) (range, 744–
4659 pixels) for ob/ob mice.
The variance of signal intensity 
within epididymal adipose tissue (V) that 
is dominated by the amount of suscep-
tibility artifacts caused by the presence 
of compartmentalized USPIO particles 
(16,17) was calculated as follows:
2
mean
(SD ),
SI
 V
where SImean is the mean signal intensity 
within the epididymal region of interest 
and SD is the standard deviation of sig-
nal intensity.
Cellular Imaging by Using  
MR Imaging
MR imaging was performed with a 4.7-T 
small-animal MR imaging system (Bio-
Spec USR47/40; Bruker BioSpin, Billeri-
ca, Mass) with a 40-cm bore and a ded-
icated coil. All animals were weighed on 
the day of MR imaging procedures. An-
esthesia was achieved by using continu-
ous isoflurane inhalation (Aerrane; Bax-
ter, Maurepas, France) monitored with 
a respiratory trigger and was maintained 
during all MR imaging procedures. A 
three-dimensional T2*-weighted gradi-
ent-echo sequence was selected owing 
to its sensitivity to USPIO-induced sus-
ceptibility artifacts (13) (repetition time, 
20 msec; echo time, 5 msec; 40 3 40 3 
30-mm field of view; flip angle, 1.5°; 400 
3 400 3 256 matrix). A mean of 200 
sections (range, 115–256 sections) were 
acquired, encompassing both subcutane-
ous and epididymal adipose tissue.
Image Analysis
Regions of interest were placed by a 
radiologist (A.L., with 10 years of ex-
perience in abdominal MR imaging) in 
the epididymal adipose tissue on two 
Figure 1
Figure 1: Diagram shows a total of 34 mice included in the experimental setup, including 17 ob/ob and 17 ob/+ mice of 7, 10, and 
14 weeks old (wo). A total of 21 mice were injected with P904 (10 ob/ob and 11 ob/+), and 13 mice were used as noninjected controls 
(seven ob/ob and six ob/+). IV = intravenous.
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The variance of signal intensity 
within the epididymal adipose tissue 
observed at MR imaging was correlated 
to body weight and expression of pro-
inflammatory markers within adipose 
tissue. The signal intensity changes 
obtained at USPIO-enhanced MR imag-
ing in the adipose tissue of aging ob/
ob mice were compared with those 
of their age-matched lean ob/+ litter-
mates. Variance of signal values were 
also correlated to the percentage of 
F4/80 positive cells depicted at patho-
logic examination.
Last, the total amount of iron oxides 
within the epididymal adipose tissue 
measured at EPR imaging was corre-
lated to the variance of signal observed 
at MR imaging, to the number of F4/80 
positive cells, and to body weight.
Results were expressed as means 6 
standard errors of the mean and were 
analyzed by using either the Mann-Whit-
ney test or Student t test as appropri-
ate (PRISM 4.0, Macintosh; GraphPad 
Software, La Jolla, Calif). Correlations 
were performed by using the Pearson 
correlation test. P value less than .05 was 
taken as the minimum level of 
significance.
Results
USPIO injection resulted in clear MR 
imaging susceptibility artifacts within 
epididymal adipose tissue in both ob/
ob and ob/+ injected mice (Fig 2, A). 
The signal intensity variance was signif-
icantly higher in USPIO-injected ob/ob 
mice than in noninjected ob/ob mice at 
7 weeks (286 6 49 [standard error of 
the mean] and 99 6 8, respectively, P 
, .01) and at 10 weeks (440 6 67 and 
138 6 9, respectively, P , .001). Sec-
tions of excised adipose tissue stained 
with Perls to detect iron confirmed that 
Perls staining colocalized with F4/80 
positive adipose tissue macrophages in 
injected animals but not in noninjected 
controls (Fig 2, B and C). Importantly, 
USPIO injections did not promote mac-
rophage infiltration within adipose tis-
sue. Indeed, there was no significant 
difference in F4/80 staining between 
injected and noninjected ob/ob animals 
or ob/+ animals (Fig 2, B).
iron. Transmission electron microscopy 
was used to colocalize USPIO particles 
within adipose tissue macrophages.
For transmission electron micro-
scopic analysis, 1-mm3 pieces of freshly 
excised tissue were fixed with 2% glu-
taraldehyde in 0.1 mol/L sodium (pH 
of 7.2) cacodylate buffer for 4 hours 
at room temperature and then post-
fixed with 1% osmium tetroxide con-
taining 1.5% potassium cyanoferrate, 
stained with uranyl acetate 2% in 
water, gradually dehydrated in ethanol 
(30%–100%), and embedded in Epon. 
Thin sections (70 nm) of selected zones 
were collected onto 200 mesh copper 
grids and counterstained with lead cit-
rate before examination with an elec-
tron microscope (Zeiss EM902; Carl 
Zeiss, Le Pecq, France) operated at 
80 kV (MIMA2-UR1196 Genomics and 
Physiology of Lactation, INRA, Plateau 
Electron Microscopy, Jouy-en-Josas, 
France). Microphotographs were ac-
quired with a camera (MegaView III 
CCD; Olympus, Münster, Germany) 
and analyzed with ITEM software 
(Eloïse-SARL, Roissy CDG, France) by 
an author (V.D.).
Statistical Analysis
Mean mice body weight, levels of ep-
ididymal adipose tissue inflammation 
depicted at immunohistochemistry, and 
expression of proinflammatory markers 
were compared in ob/ob animals and 
their lean ob/+ littermates. An overall 
analysis of variance test was performed 
on variance of signal values, followed 
by Dunn multiple comparison tests. In 
addition, an analysis of variance test 
was applied comparing signal variance 
values for each age (7, 10, and 14 weeks 
old), followed by pairwise comparisons 
between injected and noninjected ob/
ob and ob/+ animals.
The variance of signal intensity 
within the epididymal adipose tissue 
observed at MR imaging was compared 
between ob/ob injected animals and 
controls. In addition, variance values 
observed in aging ob/ob animals were 
compared. Similarly, variance values 
were compared between P904-injected 
ob/ob animals and P904-injected ob/+ 
lean littermates of the same age.
(3). Total RNA was extracted from 
mice epididymal fat by using a kit 
(RNeasyH Lipid Tissue Mini Kit; Qia-
gen, Courtaboeuf, France). Quantita-
tive reverse transcription polymerase 
chain reaction was performed with a 
LightCycler system (Roche Diagnostics, 
Meylan, France).
Oligonucleotide primer sequences of 
the mouse genes studied were as follows: 
mouse Rn18s sense 59-ACCAGAGCGA-
AAGCATTTGCCA-39 and antisense: 59 
ATCGCCAGTCGGCATCGTTTAT-39; 
mouse CCl2 sense 59-GGGCCTGCTGTT-
CACAGTT-39 and antisense 59-CCAGC-
CTACTCATTGGGAT-39; mouse Emr1 
sense 59-CTTTGGCTATGGGCTTC-
CAGTC-39 and antisense 59-GCAAGGAG-
GACAGAGTTTATCGTG-39; and mouse 
Tnf sense 59-AATGGCCTCCCTCTCAT-
C A G T T - 3 9  a n d  a n t i s e n s e 
59-CCACTTG GTGGTTTGCTACGA-39.
Polymerase chain reaction amplified 
products were analyzed with a 2% aga-
rose gel and sequenced.
USPIO Detection and Quantification and 
Transmission Electron Microscopy
Perls staining was used for localization 
of USPIO positive cells within excised 
epididymal adipose tissue.
Electron paramagnetic resonance 
(EPR) imaging was used for specific 
USPIO quantification on excised epidid-
ymal adipose tissue samples desiccated 
for 3 days at 80°C. In contrast with 
atomic emission spectrometry, which 
measures all iron species in an organ 
(including endogenous heme and non-
heme iron), EPR imaging performed at 
300 K measures only the characteristic 
wide spectrum of superparamagnetic 
nanoparticles, because paramagnetic 
iron of deoxyhemoglobin has no signal 
at this temperature. The EPR spectrum 
of dried epididymal adipose tissue was 
recorded in a magnetic field strength 
range of 0–3300 G (0–.33 T) by using 
an EPR spectrometer (Varian E102; 
Agilent Technology, Massy, France) op-
erating at Q band (9.26 GHz). Because 
the absorption area is proportional to 
the total number of USPIOs in the EPR 
cavity (18,19), the nanoparticle content 
in each sample can be computed with 
a detection sensitivity of 1022 µg of 
790 radiology.rsna.org n Radiology: Volume 263: Number 3—June 2012
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oxide nanoparticles within the epidid-
ymal adipose tissue was correlated to 
the variance of signal observed at MR 
imaging (r = 0.87, P , .0001) and to 
the number of F4/80 positive cells (r 
= 0.88, P , .0001) (Fig 5). The per-
centage of F4/80 positive cells was also 
correlated to MR imaging signal vari-
ance (r = 0.72, P , .0001). Moreover, 
the increase in iron oxide quantification 
paralleled body weight gain (r = 0.97, 
P , .001). Last, transmission electron 
microscopic experiment results con-
firmed the presence of clustered USPIO 
particles within endosomes or lyso-
somes of adipose tissue macrophages 
(Fig E2 [online]).
of their wild-type counterparts, with 
steady increase in weight with age and a 
parallel increase in macrophage-related 
adipose tissue inflammation (Fig 4, Fig E1 
[online]) (3,17). The variance of signal 
within epididymal adipose tissue at MR 
imaging induced by USPIO injection in 
ob/ob mice correlated to both the number 
of F4/80 positive cells as assessed at im-
munohistochemistry (r = 0.60, P , .01) 
and to the messenger RNA expression of 
proinflammatory markers within adipose 
tissue, including CCl2, Tnfa, and Emr1 
RNA quantification (r = 0.55, 0.56, and 
0.58, respectively; P , .01).
EPR quantification demonstrated 
that the total number of P904 iron 
Susceptibility artifacts induced by 
USPIO uptake visually increased with 
age (Fig 3a). In keeping with these 
findings, significantly higher signal vari-
ance values were present within epidid-
ymal adipose tissue of USPIO-injected 
14-week-old ob/ob animals compared 
with 10-week-old P904-injected ob/ob 
mice or 7-week-old P904-injected ob/
ob animals (Fig 3b). Significantly higher 
variance values were detected within 
epididymal adipose tissue of USPIO-
injected ob/ob mice compared with 
USPIO-injected ob/+ mice at 7, 10, and 
14 weeks of age (Fig 3b).
As expected, body weight of ob/ob 
mice was significantly higher than that 
Figure 2
Figure 2: USPIO-enhanced MR imaging allows specific cellular imaging of adipose tissue macrophages. The levels of MR imaging 
susceptibility artifacts induced by USPIO injection parallel increased adipose tissue inflammation in obese mice. A, Sagittal three-dimen-
sional T2*-weighted gradient-echo MR images in ob/+ and ob/ob animals, with and without injection of USPIO P904. Increased levels 
of susceptibility artifacts are noted within epididymal adipose tissue after P904 injection in ob/ob animals (! = subcutaneous adipose 
tissue, > = epididymal adipose tissue). B, Immunostaining with F4/80 monoclonal antibody (original magnification, 3200; inset: origi-
nal magnification, 3400) of epididymal adipose tissue of corresponding mice. F4/80 positive cells are pink stained. Increased levels of 
F4/80 positive cells are present in ob/ob animals. No difference is depicted between noninjected and injected animals of the same age 
and type. C, Perls staining (original magnification, 3200; inset: original magnification, 3400) on serial adipose tissue sections. Iron 
deposits are blue stained.
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This study had several limitations. 
The experimental setup was restricted 
to a genetic mice model of obesity and 
to the investigation of one injected dose 
and one optimal time point after P904 
injection. However, the ob/ob animal 
model used in our study is not novel 
(24). In addition, the pathologic findings 
of this study confirmed data in the liter-
ature, showing early and increasing infil-
tration of adipose tissue by macrophages 
MR signal variance. P904 USPIOs were 
taken up by adipose tissue macrophages 
and were localized to the intracellular 
lysosomal compartments, thus creating 
easily detected local magnetic field dis-
tortions. Quantification of USPIO-loaded 
adipose tissue macrophages correlated 
to the messenger RNA expression of 
proinflammatory markers and to MR 
imaging signal variance in visceral adi-
pose tissue of weight-increasing mice.
Discussion
Obesity is often considered a chronic 
low-grade inflammatory state similar to 
atherosclerosis or type II diabetes (20). 
Accumulation of immune cells in adi-
pose tissue, particularly macrophages, 
is an important component of obesity-
associated adipose tissue inflamma-
tion and contributes through increased 
systemic concentrations of inflammatory 
cytokines, including tumor necrosis fac-
tor a, interleukin-6, and resistin, to the 
development of insulin resistance and 
metabolic syndrome (1). Quantification 
of these proinflammatory markers in 
the blood can be performed, but their 
direct and specific link to the intensity 
of macrophage-related adipose tissue 
inflammation can only be demonstrated 
by the simultaneous quantification of 
adipose tissue macrophages. USPIO-
enhanced MR imaging can depict mac-
rophages within atherosclerotic walls 
and is nearing clinical use (21). Vessel 
walls with pronounced accumulation 
of macrophages appear more prone to 
instability and favor vessel thrombosis. 
Moreover, inflammation within steatotic 
liver has been reported to influence the 
degree of liver enhancement at MR im-
aging after USPIO injection (22). Hence, 
USPIO uptake within macrophages pre-
sent within atherosclerotic vessels and 
liver can be detected at MR imaging. 
Current imaging techniques can assess 
the distribution and amount of adipose 
tissue throughout the body. Total vis-
ceral adipose tissue amount is indeed 
correlated to insulin resistance, steato-
sis, and atherosclerosis (23) and can 
be monitored by using T1-weighted MR 
imaging or spectroscopy (14). However, 
to our knowledge, MR imaging has not 
been used to monitor macrophage-relat-
ed inflammation in the adipose tissue. 
This study demonstrated that cellular 
imaging by using USPIO-enhanced MR 
imaging allows detection, localization, 
and quantification of increasing levels 
of adipose tissue macrophage–related 
inflammation within visceral adipose tis-
sue. Leptin-deficient mice with increas-
ing weight showed differential accumu-
lation of USPIO within adipose tissue, 
resulting in significant increase of the 
Figure 3
Figure 3: USPIO-enhanced MR imaging allows detection of increasing levels of adipose tissue macro-
phage–related inflammation. The signal intensity variance within adipose tissue assessed at MR imaging 
after USPIO-particle injection correlates with the presence of an increased number of adipose tissue 
macrophages, increased body weight, and inflammation. (a) Three-dimensional sagittal T2*-weighted 
gradient-echo MR images of epididymal adipose tissue in three distinct ob/ob mice at 7, 10, and 14 weeks 
old (wo) show the increasing levels of susceptibility artifacts (arrows) within epididymal adipose tissue of 
elder mice consistent with the presence of USPIO. (b) Graph shows signal variance of epididymal adipose 
tissue depicted at MR imaging was significantly higher in USPIO-injected ob/ob mice than in noninjected ob/
ob mice at 10 and 14 weeks (W) of age. In addition, significantly higher variance values were detected within 
epididymal adipose tissue of USPIO-injected ob/ob mice compared with USPIO-injected ob/+ mice of 7, 10, 
and 14 weeks of age (∗ = P = .05, ∗∗ = P , .01, ∗∗∗ = P , .001). Error bars = standard deviation.
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as demonstrated with F4/80+ staining 
(3). The animals included in this study 
were not longitudinally followed-up by 
using MR imaging, despite the fact that 
MR imaging would potentially allow 
noninvasive and repeated examination 
of animals or humans with time. The 
design of our study required that path-
ologic data had to support each MR ac-
quisition. Moreover, the sample size was 
small, with only 34 mice included in this 
study. Here, the kinetics of USPIO accu-
mulation in adipose tissue macrophage 
was not investigated at short times after 
injection; but, the long-term biodistri-
bution, biotransformation, and fate of 
P904 USPIO was assessed in a previous 
3-month follow-up study (19). We chose 
to image at day 10 after injection of P904 
because we found the highest accumula-
tion of P904 in epididymal adipose tis-
sue at this time point (0.2% of injected 
Figure 4
Figure 4: Graphs show changes in inflammation in aging ob/+ and ob/ob animals. Aging ob/ob mice 
showed significant induction of the messenger RNA expression of proinflammatory markers (a) Tnfa and (b) 
Emr1 in ob/ob animals (∗ = P , .01, ∗∗ = P , .001). W = weeks. Error bars = standard deviation.
Figure 5
Figure 5: Graphs show USPIO uptake within adipose tissue macrophages is significantly correlated to MR imaging signal variance, 
progressive aging, and adipose tissue inflammation. (a) Correlation between EPR iron quantification and aging in ob/ob animals (r = 
0.97, P , .001). Error bars = standard deviation. (b) Correlation between EPR iron quantification and the percentage of F4/80 positive 
cells in ob/ob mice (r = 0.88, P , .0001). (c) Correlation between EPR iron quantification and (d) percentage of F4/80 positive cells 
and signal variance at MR imaging within epididymal adipose tissue in ob/ob animals (r = 0.87, P , .0001).
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dose), while the liver and spleen uptake 
corresponded to 30% and 1% of the in-
jected dose, respectively (19). Moreover, 
the selected dose was 1000 µmol of iron 
per kilogram, which is far beyond the 
dose to be tested in humans (because 
clinical trials and applications dosages of 
USPIO or superparamagnetic iron oxide 
are in the order of 12–45 µmol of iron 
per kilogram of body weight). Further 
experiments investigating the effect of 
reduced P904 dose injection are cur-
rently underway.
Showing that USPIO-enhanced 
MR imaging can depict adipose tis-
sue macrophages directly involved in 
obesity-related disorder initiation and 
progression could be considered a first 
step in promoting a noninvasive screen-
ing method for at-risk obese patients. 
Combined with its potential for the 
detection of inflammation within ath-
erosclerotic vessels and liver, USPIO-
enhanced MR imaging could potentially 
find a clinical application in the screen-
ing and follow-up of obese patients, po-
tentially identifying those patients with 
increased adipose tissue inflammation 
at higher risk of comorbidities. To date, 
USPIO-enhanced MR imaging hence 
appears as an interesting noninvasive 
tool for the monitoring of inflammation 
accompanying obesity-related disorders 
in animal models of obesity. This could 
allow noninvasive longitudinal follow-up 
of macrophage-related inflammation, 
which is crucial when dealing with new 
therapeutic investigations (25).
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